Plant-Based Vaccines: Antigen Design, Diversity, and Strategies for High Level Production.
COVID 19
antigens
biopharming
influenza
viral vectors
virus
virus-like particles
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
10 Jan 2022
10 Jan 2022
Historique:
received:
12
11
2021
revised:
25
12
2021
accepted:
01
01
2022
entrez:
22
1
2022
pubmed:
23
1
2022
medline:
23
1
2022
Statut:
epublish
Résumé
Vaccines for human use have conventionally been developed by the production of (1) microbial pathogens in eggs or mammalian cells that are then inactivated, or (2) by the production of pathogen proteins in mammalian and insect cells that are purified for vaccine formulation, as well as, more recently, (3) by using RNA or DNA fragments from pathogens. Another approach for recombinant antigen production in the last three decades has been the use of plants as biofactories. Only have few plant-produced vaccines been evaluated in clinical trials to fight against diseases, of which COVID-19 vaccines are the most recent to be FDA approved. In silico tools have accelerated vaccine design, which, combined with transitory antigen expression in plants, has led to the testing of promising prototypes in pre-clinical and clinical trials. Therefore, this review deals with a description of immunoinformatic tools and plant genetic engineering technologies used for antigen design (virus-like particles (VLP), subunit vaccines, VLP chimeras) and the main strategies for high antigen production levels. These key topics for plant-made vaccine development are discussed and perspectives are provided.
Identifiants
pubmed: 35062761
pii: vaccines10010100
doi: 10.3390/vaccines10010100
pmc: PMC8782010
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Consejo Nacional de Ciencia y Tecnología
ID : CB-A1-S-17585
Références
Curr Top Microbiol Immunol. 1999;240:95-118
pubmed: 10394717
Mol Biotechnol. 2013 Jan;53(1):92-107
pubmed: 23001867
Plant Cell. 2013 Jul;25(7):2429-43
pubmed: 23839786
J Biomed Biotechnol. 2010;2010:297505
pubmed: 20671958
Nat Commun. 2017 Aug 15;8(1):245
pubmed: 28811473
Adv Drug Deliv Rev. 2019 May;145:119-129
pubmed: 30172923
Expert Rev Vaccines. 2014 Jun;13(6):737-49
pubmed: 24766405
Planta. 2016 Mar;243(3):675-85
pubmed: 26613600
Plant Biotechnol J. 2015 Oct;13(8):1017-22
pubmed: 26333301
Plant Physiol. 2007 Dec;145(4):1129-43
pubmed: 18056863
Nat Med. 1998 May;4(5):607-9
pubmed: 9585236
J Infect Dis. 2000 Jul;182(1):302-5
pubmed: 10882612
BMC Bioinformatics. 2017 Feb 13;18(1):106
pubmed: 28193166
Science. 1988 Jun 10;240(4858):1534-8
pubmed: 2897716
Vaccine. 2021 Mar 5;39(10):1528-1533
pubmed: 33581920
Plant Biotechnol J. 2012 Jan;10(1):95-104
pubmed: 21883868
Mol Gen Genet. 1996 Jun 12;251(3):373-80
pubmed: 8676881
Vaccine. 2004 Oct 22;22(31-32):4385-9
pubmed: 15474732
Proc Natl Acad Sci U S A. 1992 Dec 15;89(24):11745-9
pubmed: 1465391
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Biotechnol Bioeng. 2014 Mar;111(3):425-40
pubmed: 24347238
Front Microbiol. 2017 May 03;8:788
pubmed: 28515719
Influenza Other Respir Viruses. 2007 Jan;1(1):19-25
pubmed: 19453476
Lancet. 2020 Nov 7;396(10261):1464-1465
pubmed: 33065033
Methods Mol Biol. 2010;655:65-75
pubmed: 20734254
Protein Eng Des Sel. 2009 Mar;22(3):113-20
pubmed: 19074155
Vaccine. 2018 Apr 12;36(16):2147-2154
pubmed: 29550194
Proteins. 2006 Oct 1;65(1):40-8
pubmed: 16894596
Trends Biotechnol. 2003 Dec;21(12):570-8
pubmed: 14624867
Plant J. 2006 Feb;45(4):651-83
pubmed: 16441354
Annu Rev Immunol. 1989;7:601-24
pubmed: 2469442
Science. 1981 Jun 12;212(4500):1229-38
pubmed: 6165083
Transgenic Res. 2008 Aug;17(4):621-31
pubmed: 17882531
Curr Opin Biotechnol. 2006 Apr;17(2):147-54
pubmed: 16459071
Vaccine. 2005 Mar 18;23(17-18):2042-8
pubmed: 15755568
Front Immunol. 2017 Mar 17;8:292
pubmed: 28367149
Vaccines (Basel). 2021 Jul 08;9(7):
pubmed: 34358177
PLoS Comput Biol. 2012;8(12):e1002829
pubmed: 23300419
Biotechnology. 1992;24:367-70
pubmed: 1422041
Ann Med. 2018 Mar;50(2):110-120
pubmed: 29172780
Plant Biotechnol J. 2019 Sep;17(9):1751-1759
pubmed: 30791210
Expert Rev Vaccines. 2008 Oct;7(8):1173-83
pubmed: 18844592
Curr Top Microbiol Immunol. 2014;375:19-45
pubmed: 22038412
Methods Mol Biol. 2005;286:35-46
pubmed: 15310911
Vaccine. 2007 Nov 28;25(49):8228-40
pubmed: 17976876
Vaccine. 1998 Aug;16(13):1336-43
pubmed: 9682399
Pharmaceutics. 2019 May 11;11(5):
pubmed: 31083495
Nat Biotechnol. 2005 Jun;23(6):718-23
pubmed: 15883585
Plant Mol Biol. 1990 Dec;15(6):809-19
pubmed: 2103474
BMC Bioinformatics. 2007 Jan 05;8:4
pubmed: 17207271
BMC Vet Res. 2019 Dec 3;15(1):432
pubmed: 31796116
Viral Immunol. 2006 Spring;19(1):42-53
pubmed: 16553549
Vaccine. 2005 Mar 7;23(15):1851-8
pubmed: 15734055
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2020 Mar;12(2):e1587
pubmed: 31486296
Lancet. 2020 Nov 7;396(10261):1491-1503
pubmed: 33065035
Nature. 1982 Jul 22;298(5872):347-50
pubmed: 7045698
Expert Rev Vaccines. 2013 Feb;12(2):211-24
pubmed: 23414411
FASEB J. 1999 Oct;13(13):1796-9
pubmed: 10506582
Trends Genet. 2004 Aug;20(8):375-83
pubmed: 15262410
BMC Bioinformatics. 2013 Jul 01;14:211
pubmed: 23815072
Plant Biotechnol J. 2007 Sep;5(5):555-69
pubmed: 17645439
Nucleic Acids Res. 2017 Jul 3;45(W1):W24-W29
pubmed: 28472356
Biology (Basel). 2021 Sep 26;10(10):
pubmed: 34681059
J Comput Chem. 2010 Jan 30;31(2):455-61
pubmed: 19499576
Vaccine. 2014 Oct 21;32(46):6098-106
pubmed: 25240757
Plant Biotechnol J. 2016 Nov;14(11):2190-2200
pubmed: 27155248
J Biotechnol. 2020 Jul 20;318:51-56
pubmed: 32387449
Methods Mol Biol. 1995;49:39-48
pubmed: 8563823
Biotechnol Bioeng. 2010 May 1;106(1):9-17
pubmed: 20047189
Plant Biotechnol J. 2019 Jul;17(7):1357-1368
pubmed: 30575284
Curr Opin Genet Dev. 1993 Feb;3(1):91-6
pubmed: 8453279
Trends Biotechnol. 2003 Mar;21(3):95-8
pubmed: 12628361
Nucleic Acids Res. 1984 Nov 26;12(22):8711-21
pubmed: 6095209
Plant Biotechnol J. 2019 Jul;17(7):1408-1417
pubmed: 30578710
Curr Pharm Des. 2013;19(31):5574-86
pubmed: 23394571
Biotechnol Adv. 2009 Nov-Dec;27(6):733-743
pubmed: 19460424
Plant Biotechnol J. 2015 Oct;13(8):1033-40
pubmed: 25828481
Clin Exp Vaccine Res. 2021 Jan;10(1):13-23
pubmed: 33628750
Nucleic Acids Res. 2017 Apr 7;45(6):3519-3527
pubmed: 27903913
Curr Opin Biotechnol. 2014 Apr;26:7-13
pubmed: 24679252
Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15050-5
pubmed: 10611336
Bioinformatics. 2005 Feb 15;21(4):483-91
pubmed: 15374866
Nat Biotechnol. 2001 Sep;19(9):870-5
pubmed: 11533648
Virus Res. 2018 Jan 15;244:213-217
pubmed: 29196195
Plant Biotechnol J. 2010 Jan;8(1):38-46
pubmed: 19929900
Nat Med. 2021 Jun;27(6):1071-1078
pubmed: 34007070
Vaccine. 2017 Aug 16;35(35 Pt B):4629-4636
pubmed: 28712489
Vet Res. 2018 Oct 11;49(1):105
pubmed: 30309390
J Immunol. 2004 Sep 1;173(5):3148-54
pubmed: 15322175
Expert Rev Vaccines. 2020 Mar;19(3):235-246
pubmed: 32133886
Vaccines (Basel). 2021 Sep 06;9(9):
pubmed: 34579229
BMC Biotechnol. 2006 Jul 18;6:35
pubmed: 16848907
Hum Vaccin. 2011 Mar;7(3):331-8
pubmed: 21358270
Biotechnol Adv. 2019 Nov 15;37(7):107413
pubmed: 31251968
Ther Adv Vaccines. 2015 Sep;3(5-6):139-54
pubmed: 26668752
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Science. 1995 May 5;268(5211):714-6
pubmed: 7732379
Nature. 1989 Dec 7;342(6250):692-6
pubmed: 2594067
Inflammopharmacology. 2018 Jun;26(3):817-827
pubmed: 29094307
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W363-7
pubmed: 15980490
Plant Cell Rep. 1986 Apr;5(2):81-4
pubmed: 24248039